Pertussis Vaccine Industry Research Report 2024

Pertussis Vaccine Industry Research Report 2024


Summary
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

According to APO Research, the global Pertussis Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.

The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Sanofi PasteurGSKMitsubishi Tanabe PharmaWuhan Institute of Biological ProductsWalvax BiotechnologyMinhai BiotechnologyKM BiologicsChengdu Institute of Biological ProductsPertussis Vaccine segment by Type
Whole-cell VaccinesAcellular VaccinesPertussis Vaccine segment by Application

12 Months Below
12 Months AbovePertussis Vaccine Segment by Region
North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaChina TaiwanIndonesiaThailandMalaysiaLatin AmericaMexicoBrazilArgentinaMiddle East & AfricaTurkeySaudi ArabiaUAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pertussis Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pertussis Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Pertussis Vaccine Sales (2019-2030)
2.2.3 Global Pertussis Vaccine Market Average Price (2019-2030)
2.3 Pertussis Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Whole-cell Vaccines
2.3.3 Acellular Vaccines
2.4 Pertussis Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 12 Months Below
2.4.3 12 Months Above
3 Market Competitive Landscape by Manufacturers
3.1 Global Pertussis Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Pertussis Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Pertussis Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Pertussis Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Pertussis Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pertussis Vaccine, Product Type & Application
3.8 Global Manufacturers of Pertussis Vaccine, Date of Enter into This Industry
3.9 Global Pertussis Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Business Overview
4.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
4.1.5 Sanofi Pasteur Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Pertussis Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 Mitsubishi Tanabe Pharma
4.3.1 Mitsubishi Tanabe Pharma Company Information
4.3.2 Mitsubishi Tanabe Pharma Business Overview
4.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
4.3.5 Mitsubishi Tanabe Pharma Recent Developments
4.4 Wuhan Institute of Biological Products
4.4.1 Wuhan Institute of Biological Products Company Information
4.4.2 Wuhan Institute of Biological Products Business Overview
4.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
4.4.5 Wuhan Institute of Biological Products Recent Developments
4.5 Walvax Biotechnology
4.5.1 Walvax Biotechnology Company Information
4.5.2 Walvax Biotechnology Business Overview
4.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
4.5.5 Walvax Biotechnology Recent Developments
4.6 Minhai Biotechnology
4.6.1 Minhai Biotechnology Company Information
4.6.2 Minhai Biotechnology Business Overview
4.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
4.6.5 Minhai Biotechnology Recent Developments
4.7 KM Biologics
4.7.1 KM Biologics Company Information
4.7.2 KM Biologics Business Overview
4.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 KM Biologics Pertussis Vaccine Product Portfolio
4.7.5 KM Biologics Recent Developments
4.8 Chengdu Institute of Biological Products
4.8.1 Chengdu Institute of Biological Products Company Information
4.8.2 Chengdu Institute of Biological Products Business Overview
4.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
4.8.5 Chengdu Institute of Biological Products Recent Developments
5 Global Pertussis Vaccine Market Scenario by Region
5.1 Global Pertussis Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Pertussis Vaccine Sales by Region: 2019-2030
5.2.1 Global Pertussis Vaccine Sales by Region: 2019-2024
5.2.2 Global Pertussis Vaccine Sales by Region: 2025-2030
5.3 Global Pertussis Vaccine Revenue by Region: 2019-2030
5.3.1 Global Pertussis Vaccine Revenue by Region: 2019-2024
5.3.2 Global Pertussis Vaccine Revenue by Region: 2025-2030
5.4 North America Pertussis Vaccine Market Facts & Figures by Country
5.4.1 North America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Pertussis Vaccine Sales by Country (2019-2030)
5.4.3 North America Pertussis Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Pertussis Vaccine Market Facts & Figures by Country
5.5.1 Europe Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Pertussis Vaccine Sales by Country (2019-2030)
5.5.3 Europe Pertussis Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pertussis Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Pertussis Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Pertussis Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pertussis Vaccine Market Facts & Figures by Country
5.7.1 Latin America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Pertussis Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Pertussis Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Pertussis Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Pertussis Vaccine Sales by Type (2019-2030)
6.1.1 Global Pertussis Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Pertussis Vaccine Revenue by Type (2019-2030)
6.2.1 Global Pertussis Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Pertussis Vaccine Price by Type (2019-2030)
7 Segment by Application
7.1 Global Pertussis Vaccine Sales by Application (2019-2030)
7.1.1 Global Pertussis Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Pertussis Vaccine Revenue by Application (2019-2030)
7.2.1 Global Pertussis Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Pertussis Vaccine Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Pertussis Vaccine Value Chain Analysis
8.1.1 Pertussis Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pertussis Vaccine Production Mode & Process
8.2 Pertussis Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pertussis Vaccine Distributors
8.2.3 Pertussis Vaccine Customers
9 Global Pertussis Vaccine Analyzing Market Dynamics
9.1 Pertussis Vaccine Industry Trends
9.2 Pertussis Vaccine Industry Drivers
9.3 Pertussis Vaccine Industry Opportunities and Challenges
9.4 Pertussis Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings